These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


63 related items for PubMed ID: 3607585

  • 21. Effects of acebutolol combined with mefruside on total-body and serum potassium in essential hypertensive patients.
    Schulte KL, Meyer-Sabellek W, Gotzen R.
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):438-40. PubMed ID: 6490227
    [Abstract] [Full Text] [Related]

  • 22. Interaction between beta blockers and epinephrine on hemodynamics of spontaneously hypertensive rats.
    Kim Y.
    Res Commun Chem Pathol Pharmacol; 1993 Apr; 80(1):3-19. PubMed ID: 8488340
    [Abstract] [Full Text] [Related]

  • 23. [Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].
    Lil'in ET, Vavilova TA, Mar'in MI.
    Klin Med (Mosk); 1983 Sep; 61(9):85-9. PubMed ID: 6139506
    [No Abstract] [Full Text] [Related]

  • 24. [The use of acebutolol in arterial hypertension. Apropos of 31 case records of Senegalese patients].
    Koaté P, Diouf S, Sylla M, Diop G, Sarr M, Ba SA.
    Dakar Med; 1983 Sep; 28(2):299-319. PubMed ID: 6653328
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of hypertension with acebutolol.
    Fah NT.
    Med J Malaysia; 1977 Dec; 32(2):127-32. PubMed ID: 614478
    [No Abstract] [Full Text] [Related]

  • 26. Rapid identification of diabetic patients with essential hypertension sensitive to acebutolol.
    Passa P, Tugaye A, Gauville C, Canivet J.
    Diabete Metab; 1981 Sep; 7(3):155-9. PubMed ID: 7033007
    [Abstract] [Full Text] [Related]

  • 27. [Evaluation of the hypotensive effect of acebutolol (Sectral)].
    Brym E, Cybulska I, Czerniewska E.
    Pol Tyg Lek; 1982 Nov 15; 37(44):1323-6. PubMed ID: 6761673
    [No Abstract] [Full Text] [Related]

  • 28. [Cardiovascular complications in hypertensive patients during the peroperative phase].
    Hartung HJ, Osswald PM, Roller G, Lutz H.
    Anasth Intensivther Notfallmed; 1983 Aug 15; 18(4):196-8. PubMed ID: 6638421
    [Abstract] [Full Text] [Related]

  • 29. Comparative study of muzolimine and acebutolol in the treatment of moderate hypertension.
    Lucsko M, Kerihuel JC, Chaignon M, Aubert PH, Guedon J.
    Z Kardiol; 1985 Aug 15; 74 Suppl 2():73-6. PubMed ID: 3890394
    [Abstract] [Full Text] [Related]

  • 30. A comparison of acebutolol with methyldopa in hypertensive pregnancy.
    Williams ER, Morrissey JR.
    Pharmatherapeutica; 1983 Aug 15; 3(7):487-91. PubMed ID: 6669592
    [Abstract] [Full Text] [Related]

  • 31. Treatment of hypertension in the elderly with a low dose combination of a beta-adrenoceptor blocker and a thiazide diuretic: comparison with methyldopa.
    Down PF, Rao SK, Braverman AM, Poloniecki JD.
    Br J Clin Pract; 1983 Aug 15; 37(11-12):371-4, 388. PubMed ID: 6367793
    [No Abstract] [Full Text] [Related]

  • 32. [Acebutolol: experience with its use in ambulatory management of arterial hypertension].
    Battaglia A, Adamo M.
    Minerva Med; 1983 Mar 10; 74(9-10):493-8. PubMed ID: 6340002
    [Abstract] [Full Text] [Related]

  • 33. [Acebutolol as monotherapy of essential arterial hypertension].
    Mazzaferro S, Giuliano G, Lucchini M, Airoldi G, Finistauri D, Massimetti C, Messa F, Coen G.
    Clin Ter; 1984 May 31; 109(4):315-21. PubMed ID: 6236025
    [No Abstract] [Full Text] [Related]

  • 34. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM, Rabot D, Herrero G.
    J Cardiovasc Pharmacol; 1990 May 31; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [Abstract] [Full Text] [Related]

  • 35. [Hemodynamic effects of intravenous acebutolol in the acute phase of myocardial infarction].
    Metzger JP, Montgermont P, N'Koua JL, Baubion N, Adams C, Meilhac B, Le Pailleur C, Vacheron A.
    Ann Cardiol Angeiol (Paris); 1985 Jun 31; 34(6):377-80. PubMed ID: 4026163
    [Abstract] [Full Text] [Related]

  • 36. [Hemodynamic and coronary metabolic effects of the cold test before and after acebutolol].
    Guiomard A, Zygelman M, Evstigneff T, Bréaud N, Roland E, Pansard Y, Mérillon JP, Gourgon R.
    Arch Mal Coeur Vaiss; 1983 Feb 31; 76 Spec No():77-85. PubMed ID: 6134512
    [No Abstract] [Full Text] [Related]

  • 37. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O, Johansson BW.
    J Hypertens Suppl; 1993 Jun 31; 11(4):S55-60. PubMed ID: 8104242
    [Abstract] [Full Text] [Related]

  • 38. Changes in serum lipids and antioxidant status in west Algerian patients with essential hypertension treated with acebutolol compared to healthy subjects.
    Krouf D, Bouchenak M, Mohammedi B, Cherrad A, Belleville JL, Prost JL.
    Med Sci Monit; 2003 Aug 31; 9(8):PI109-15. PubMed ID: 12942043
    [Abstract] [Full Text] [Related]

  • 39. Beneficial effects of beta-adrenergic blockade in coronary artery surgery: clinical research.
    Yorulmaz FM, Kuralay E, Tatar H, Süer H, Oztürk OY.
    Cardiovasc Surg; 1993 Aug 31; 1(4):410-3. PubMed ID: 7915625
    [Abstract] [Full Text] [Related]

  • 40. [Comparative studies with beta blockers in hypertensive patients in ambulatory care].
    Hagel F.
    Med Welt; 1982 Feb 05; 33(5):185-7. PubMed ID: 7070274
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.